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Abstract
Background: The creation of a complete genome-wide map of transcription factor binding sites is essential for
understanding gene regulatory networks in vivo. However, current prediction methods generally rely on statistical
models that imperfectly model transcription factor binding. Generation of new prediction methods that are based
on protein binding data, but do not rely on these models may improve prediction sensitivity and specificity.
Results: We propose a method for predicting transcription factor binding sites in the genome by directly mapping
data generated from protein binding microarrays (PBM) to the genome and calculating a moving average of
several overlapping octamers. Using this unique algorithm, we predicted binding sites for the essential pancreatic
islet transcription factor Nkx2.2 in the mouse genome and confirmed >90% of the tested sites by EMSA and ChIP.
Scores generated from this method more accurately predicted relative binding affinity than PWM based methods.
We have also identified an alternative core sequence recognized by the Nkx2.2 homeodomain. Furthermore, we
have shown that this method correctly identified binding sites in the promoters of two critical pancreatic islet β-
cell genes, NeuroD1 and insulin2, that were not predicted by traditional methods. Finally, we show evidence that
the algorithm can also be applied to predict binding sites for the nuclear receptor Hnf4a.
Conclusions: PBM-mapping is an accurate method for predicting Nkx2.2 binding sites and may be widely
applicable for the creation of genome-wide maps of transcription factor binding sites.
Background
The dynamic process of gene regulation is essential for
embryonic development and cellular function. Gene
regulation is primarily mediated by the combinatorial
effects of transcription factors interacting with cis-
regulatory elements such as promoters and enhancers.
Therefore, accurate identification of transcription factor
binding sites within the genome is necessary to under-
stand a wide range of cellular processes from cell differ-
entiation to homeostasis to cancer. However, identifying
these sites within the genome remains a complex
biological and computational question.
One of the challenges in predicting transcription fac-
tor binding sites is that identification of the strongest
binding sequence, or consensus site, is not sufficient.
Research analyzing genome wide transcription factor
occupancy has shown that low affinity binding sites are
also significantly occupied in both yeast and Drosophila
[1,2]. Furthermore, transcription factors from the same
family have been shown to bind identical high affinity
sites, but distinct low affinity sites [3,4]. Therefore, iden-
tification of both high and low affinity sites will be
essential to fully understand transcription factor specifi-
city within the genome.
Current transcription factor motif algorithms generally
rely on a statistical model, such as a position weight
matrix (PWM), generated with information derived
from homology between co-regulated promoters, con-
served regions in orthologous genes, known binding
sites, or in vitro binding assays [5]. However, these
methods have a low level of specificity and sensitivity
[6-9]. This problem is due to both experimental and
theoretical errors. Experimental errors include alignment
of a limited set of binding sites [10], resulting in a PWM
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that is information poor, and non-physiological condi-
tions used in in vitro binding assays [11]. Theoretical
errors stem from assumptions used as the basis of the
PWM model. PWMs assume that contributions by indi-
vidual bases within a binding site are independent and
additive, and that the binding energy contribution is
proportional to their frequency in the position weight
matrix. However, all three of these assumptions have
been called into question. Interdependencies have been
demonstrated at least in a subset of transcription factors
resulting in contributions to binding affinity that are
both interdependent and non-additive [10,12,13]. Posi-
tion weight matrix scores have also been experimentally
shown to be a poor predictor of binding affinities in
both eukaryotic and prokaryotic systems [7,14].
Nkx2.2 is a homeodomain transcription factor
expressed in the ventral neural tube, intestine and pan-
creas [15]. A consensus sequence (T(t/c)AAGT(a/g)(c/g)
TT) has been identified by SELEX and a corresponding
PWM was generated and deposited in the TRANSFAC
database [16]. However, experiences in our lab and
others have shown that the predictive power of this
PWM is low. More recently, Berger et al. [4] generated
a PWM for Nkx2.2 using protein binding microarray
(PBM) technology. PBMs use a mathematically con-
structed set of oligos to quantitatively measure protein-
DNA binding for all possible octamers. This should, in
theory, result in a PWM that is more information rich
than those constructed by other methods.
Here, we show the results of an in-depth analysis of
the PBM data for Nkx2.2. The original Nkx2.2 consensus
sequence contains an invariable “AAGT” core. We have
identified an alternative low-affinity core sequence with
a wobble in the first position to contain “GAGT”. We
also mapped the PBM data directly to the genome to
identify putative Nkx2.2 binding sites. Using this
method, we identified 111 novel Nkx2.2 binding sites
within the proximal promoters of genes differentially
expressed in wildtype and Nkx2.2 null pancreata and
confirmed approximately 90% of these sites by EMSA
and/or ChIP analysis. Six of the sites confirmed by
EMSA and ChIP contain the alternative “GAGT” core
sequence. We also show that using a moving average of
E-scores from the protein binding microarrays to predict
relative binding affinity outperformed both the TRANS-
FAC PWM and the PBM-based PWM. Since the PBM-
based PWM and the method described in this study rely
on the same input data, these results show that the
assumptions used to generate PWMs do not accurately
describe Nkx2.2 binding. Therefore, creating genome-
wide maps by directly using experimental data will
greatly increase the specificity and sensitivity of tran-
scription factor binding site (TFBS) predictions over sta-
tistical models. Furthermore, these experiments revealed
a gene battery that includes a large number of genes
required for insulin secretion functions in the b-cell that
is controlled by Nkx2.2. We demonstrate that this same
method can be adapted to other transcription factors.
Based on these findings, we propose that PBM-mapping
can be used to create composite TFBS maps across the
entire genome. Such a map would greatly aid in the
identification of cis-regulatory elements and the under-
standing of gene regulation.
Results
Identification of an alternative Nkx2.2 binding site core
sequence
Nkx2.2 was previously shown to specifically bind a 10
base-pair sequence containing an invariable “AAGT” core
sequence flanked by several less conserved bases [16]. To
date, only two in vivo binding sites (in the insulin2 and
MafA promoters) identified using this sequence have been
successfully verified [17,18]. One possible explanation for
the low predictive power of this consensus sequence is
that it does not completely encompass the possible bind-
ing motifs for Nkx2.2 binding. More recently, Berger et al.
[4] published a protein binding microarray (PBM) analyz-
ing the binding affinity of the Nkx2.2 homeodomain.
PBMs generate an enrichment score (E-score) with a
range from -0.5 (low affinity) to 0.5 (high affinity) for
every possible 8-base combination based on the relative
intensity readouts from microarray data [19]. Therefore, it
has the potential to be more information rich than other
methods because it allows for complete coverage of possi-
ble binding sequences and provides quantitative binding
results. We used this data as a basis to identify additional
Nkx2.2 DNA binding motifs.
We first selected and analyzed all Nkx2.2-bound octa-
mers with an E-score greater than 0.45 (132 octamers,
Figure 1A). Of these, 96 (73%) contained the previously
published “AAGT” core sequence or its reverse comple-
ment. Of the remaining 36 octamers, 33 (25% of the total)
had an alternative sequence “GAGT.” Three octamers did
not contain either core sequence. We next calculated the
average E-score for octamers containing AAGT and octa-
mers containing GAGT. The average of all possible octa-
mers was used as a baseline control. AAGT and GAGT
containing octamers had a mean E-score value of 0.197 and
0.160, respectively, which are significantly greater (P <<
0.001) than the mean for all possible octamers (-0.029).
Several combinations of two core sequences are possi-
ble within a single octamer. In order to identify the
effect of two adjacent cores on Nkx2.2 binding, we ana-
lyzed these “dual-core” octamers (Additional File 1).
Dual-core octamers for Nkx2.2 binding can be divided
into 4 groups based on which core sequence (AAGT or
GAGT) is included and their relative orientation (inline
or reverse compliment). Interestingly, all octamers
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containing two cores in the reverse compliment orienta-
tion had E-scores > 0.45 while octamers with inline
cores had E-scores < 0.37, independent of which cores
were contained in the octamer.
The two identified core sequence motifs differ only in
the first position. In order to determine whether
significant enrichment could be achieved with the other
two possible first position bases, we plotted a histogram
of the number of occurrences of each possible base in
the first position for all E-scores (Figure 1B). We found
that there is a significant enrichment of only the AAGT
and GAGT core sequences.
To experimentally test the alternative GAGT binding
site, we performed Electrophoretic Mobility Shift Assay
(EMSA) experiments using the previously published
Nkx2.2 consensus sequence as a baseline probe [16,20]
(Figure 1C). We mutated this probe to contain the
alternative GAGT core sequence (max E-score =
0.48593, PBM-mapping score = 0.43038) and compared
binding to both the original consensus probe (max
E-score = 0.49841, PBM-mapping score = 0.46186) and
a probe with a deleted core sequence (max E-score =
0.11739, PBM-mapping score = 0.05029). The GAGT
containing probe showed significant binding with
in vitro translated Nkx2.2 (TNT Nkx2.2) or nuclear
extract from pancreatic cell lines with or without
exogenously expressed Nkx2.2, although binding was
weaker than the AAGT containing probe. Taken
together, these experiments show that GAGT represents
an alternative core sequence for Nkx2.2 binding sites,
although its relative binding affinity is lower than the
canonical AAGT core sequence.
Identification of Novel Endogenous Nkx2.2 Binding Sites
Using Protein Binding Microarray Mapping
Several methods to predict genomic transcription factor
binding sites using PBM data have been developed. The
most common methods rely on PWM creation by the
“seed-and-wobble” algorithm or parametric methods
[19,21]. However, these methods are limited by the
inaccuracies of the PWM model. E-scores of single
octamers have also been suggested to be correlated with
transcription factor binding affinity, suggesting that they
might be able to be directly used to predict binding
sites [3]. However, the dataset of E-scores has been
shown to be somewhat noisy [21]. In order to compen-
sate for dataset noise, Grove et al. [22] used an average
of 3 E-scores based on a perfectly conserved core
sequence (the AvgES method). However, we show in
this study that the core sequence may not be comple-
tely conserved. Therefore, we sought to develop a novel
algorithm that utilizes a moving average of E-scores for
overlapping octamers to predict endogenous Nkx2.2
binding sites without the bias for PWM-derived consen-
sus core sequences and with more overlapping octamers
than were used in the AvgES method (Figure 2). We
refer to this method as PBM-mapping. Briefly, E-scores
are mapped to each octamer in the genome and a mov-
ing average of several overlapping octamers is calcu-
lated. We experimentally determined that using a
Figure 1 Nkx2.2 binds to the alternative core sequence
“GAGT”. (A) Table showing E-score distribution of octamers.
E-scores were generated using protein binding microarray data.
Octamers were divided into AAGT containing, GAGT containing and
all octamers (left column). The number of octamers in each group
with an E-score above 0.45 is shown in the middle column. Average
E-score from all octamers in each group is shown in the right
column. (B) Histogram plot of E-score distribution for AAGT, GAGT,
TAGT and CAGT. Each point represents the percentage of total sites
within a 0.10 bin that contain the given core sequence. (C) EMSA
analysis of the canonical AAGT containing consensus probe (Sup.
Table 3: “Nkx2.2 AAGT”), a GAGT core containing probe (Sup.
Table 3: “Nkx2.2 GAGT”), and a probe with no core sequence (Sup.
Table 3: “Nkx2.2 No Core”). Each probe was incubated with in vitro
synthesized Nkx2.2 (Myc tagged-Nkx2.2 TNT Protein) or aTC1 nuclear
extract with or without transfected Myc tagged-Nkx2.2.
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moving average of 7 octamers predicted binding affinity
with the greatest accuracy (see below and Figure 2B).
Sequences with a moving average higher than a deter-
mined threshold are then deposited into a database that
can be queried to identify putative sites. We show by
DNA binding assays that the threshold should be set to
approximately 0.37 for Nkx2.2, although this threshold
may vary for other transcription factors (see below).
We tested our algorithm by searching for Nkx2.2
binding sites throughout the genome. Complete analysis
of the genome resulted in 3 × 106 predicted sites, which
falls within range of the expected number of binding
sites in the genome for a single transcription factor,
based on statistical probability of the sequence occurring
in the genome. In order to investigate sites that are
most likely to be biologically relevant, we selected sites
within regulatory regions from 2.5 kb upstream to 1 kb
downstream of the transcription start site of 35 genes
with expression levels significantly (P ≤ 0.05) changed in
Nkx2.2 null embryos [23-25]. A total 111 putative bind-
ing sites were identified in 31 differentially expressed
genes including 7 of the 8 genes with increased expres-
sion in the Nkx2.2 null pancreas, and 24 of the 27 genes
with decreased expression in the Nkx2.2 null pancreas.
Furthermore, genes with differential expression in the
Nkx2.2 null embryo were more likely to have predicted
sites within 500 bp upstream of the transcriptional start
site (Additional File 2, P = .02).
We chose to test the binding of 24 putative sites that
were randomly selected from the promoters of differen-
tially expressed genes using EMSA analysis (Figure 3A).
We also included 3 predicted sites that were located
outside of the designated promoter region because they
fell in genes of particular interest, including a site in the
recently described Region IV enhancer of the Pdx1 pro-
moter [26] and additional sites in the promoter regions
of Irs4 (Irs4 +1495) and Nkx6.2 (Nkx6.2 +1669). In addi-
tion, we tested a previously published Nkx2.2 binding
site in the insulin2 promoter (Ins2 -144) that is the only
previously published Nkx2.2 site not predicted by PBM-
mapping [17]. The published Nkx2.2 site in the MafA
promoter (Mafa -7762, PBM-mapping score = 0.417)
was used as a positive control [18]. Of the 28 sites
tested by EMSA, only the Ins2 -144, the Nkx6.2 +1669,
and the glucagon -1080 sites did not show detectable
binding. Consistently, the Gcg -1080 and Nkx6.2 +1669
sites had averages E-score of 0.347 and 0.364, respec-
tively, and represented the lowest scores of any pre-
dicted site tested. The Ins2 -144 site was below our
original threshold with an average E-score of 0.233.
Although EMSA analysis shows the sequence specifi-
city of transcription factor binding, it does not take into
Figure 2 Transcription factor binding site prediction using PBM mapping. (A) Flow chart diagram outlining prediction method. (B) Diagram
showing the calculation of the moving average of E-scores. A window containing 7 overlapping octamers was generated and the mean of the
E-scores for each octamer was calculated. The sequence and score for the Nkx2.2 consensus sequence is shown.
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account cell-specific chromatin states or cooperative fac-
tors that may affect binding in vivo. In order to confirm
Nkx2.2 occupancy of these sites in b-cells, we performed
chromatin immunoprecipitation (ChIP) using the bTC6
cell line (Figure 3B). We did not include the Nkx6.2
-1441, Nkx6.2 +1669, Irs4 +1495 and Tm4sf4 +912 sites
in this analysis because they fell in low complexity
regions, which hindered the design of appropriate pri-
mers. Precipitation with the Nkx2.2 monoclonal anti-
body resulted in significant enrichment of all predicted
promoters that were tested (Figure 3B). The promoter
for the housekeeping gene GapdH was used as a nega-
tive control. This data shows that promoters containing
predicted sites are occupied in vivo. However, ChIP
results cannot distinguish between multiple sites in of
the Gcg, Ins2, Iapp, Nkx2.2, and Tm4sf4 promoters due
to the close proximity of the sites.
PBM-mapping accurately predicts relative Nkx2.2 binding
affinity in vitro
Transcription factor binding in vivo is not a binary
event but a continuum of site occupancy proportional
to the binding affinity (Ka) of the transcription factor
and its binding site. Therefore, the ideal TFBS predic-
tion algorithm would generate a score that is highly cor-
related with transcription factor binding affinity. It has
been proposed that the E-score from PBM experiments
is indicative of relative binding affinity and preliminary
experiments have shown correlation between individual
octamer E-scores and binding affinity [3,21]. Therefore,
in order to test whether single octamer and average
E-scores are correlated with relative Nkx2.2 binding affi-
nity, we quantified the fraction bound for each site in
the EMSA analysis (normalized to the probe with the
largest bound fraction) and graphed it against single
E-scores for the highest octamer and averages of 3, 5, 6,
7 or 8 oligos (Additional File 3). The fractional occu-
pancy of a transcription factor bound to a DNA binding
site is indicative of the relative binding affinities of the
ligands [27]. The average of 7 overlapping scores
showed the highest correlation with relative binding affi-
nity (r-squared = 0.666) and outperformed both the
TRANSFAC PWM score (r-squared = 0.305) and the
PBM seed and wobble matrix score (r-squared = 0.604)
(Figure 4). In order to confirm the correlation between
the PBM-mapping score and biochemically-derived
binding affinity values, we analyzed 22 binding-sites
with Kd values that were determined for the Nkx2.2 dro-
sophila homolog, vnd [28]. The homeodomains of the
fly and mouse proteins contain 95% amino acid identity
and greater than 98% similarity, therefore the Kd values
for Nkx2.2 and vnd should also be very similar. Regres-
sion analysis of PBM-mapping scores against the Kd
values for 22 vnd sites showed strong correlation (r2 =
Figure 3 Confirmation of PBM-mapping predicted sites by
EMSA and ChIP Analysis. (A) EMSA analysis of selected predicted
sites. Probes spanning approximately 50-60 bp surrounding the
predicted site were incubated with in vitro synthesized Nkx2.2. The
Nkx2.2 consensus probe and the consensus probe with the core
sequence deleted were used as positive and negative controls,
respectively. (B) Confirmation of in vivo promoter occupancy at
predicted sites by ChIP. bTC6 cells were used for chromatin input
and the Nkx2.2 mouse monoclonal antibody was used for
precipitations. Enrichment is shown as fold change over IgG. All
predicted sites were significantly increased over the IgG control (P <
0.05). The housekeeping gene GapdH was used as a negative
control and was not significantly enriched.
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0.83, Additional File 4). Taken together, these experi-
ments show that PBM-mapping represents a highly
accurate prediction method to find genome wide bind-
ing sites.
AAGT and GAGT core sequences contribute to Nkx2.2
binding in the NeuroD1 promoter
Although there is overlap between PWM based predic-
tions and PBM mapping, the predictions are significantly
different for sites within the NeuroD1 gene, which have
previously been shown to be directly regulated by Nkx2.2
[20]. In the NeuroD1 promoter, previous analysis for
Nkx2.2 binding predicted two sites that could not be con-
firmed by EMSA analysis [20] (Figure 5A). PBM-mapping
did not predict either of these sites, but predicted a novel
site at -837 that was bound in EMSA experiments
(Figure 5B, see also [20]). The PBM-mapping predicted
Nkx2.2 site within the NeuroD1 promoter is unique
because it is predicted to consist of two adjacent Nkx2.2
binding sites (Figure 5A). One binding site contains the
previously published “AAGT” core sequence while the
other has the novel “GAGT” core sequence identified in
this study. Mutation of each individual core sequence
showed a reduction in binding while mutation of both
cores simultaneously was necessary to completely ablate
Nkx2.2 binding (Figure 5B), suggesting that both cores
contribute to Nkx2.2 binding. Interestingly, we did not
detect a slower migrating protein complex forming on
the double site, suggesting that dimer formation is pre-
vented, possibly by steric hindrance. This may represent
a unique mechanism to increase transcription factor
occupancy on the promoter.
Figure 4 Linear regression of various prediction methods and relative binding affinity. In each panel, the highest score obtained from the
EMSA probe was compared to relative binding affinity (fraction bound) calculated from the EMSA in Figure 2. Probes with more than one
predicted site (Spk3 -1044 and Nkx2.2 -1503) were excluded. Scores from probes that were not bound in the EMSA (Gcg -1080, Nkx6.2 +1669,
and Ins2 -144) were plotted along the X-axis and not used for r-squared calculation. Scores used were (A)average e-score from 7 overlapping
octamers from PBM-mapping, (B) log-odds from TRANSFAC-PWM, and (C) Seed and Wobble matrix score from PBM-PWM.
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Identification of a novel Nkx2.2 binding site in the insulin
promoter
An Nkx2.2 binding site in the insulin promoter (Ins2
-144) was previously identified [17]. This site is pre-
dicted by the TRANSFAC PWM and the PBM seed and
wobble matrix, but is not predicted by PBM-mapping
(Figure 4). We were unable to confirm Nkx2.2 binding
to the previously published site by in vitro generated
Nkx2.2 (Ins2 -144, Figure 3A). However, PBM mapping
predicted a site 328 bases upstream of the previously
published site that was confirmed by EMSA (Ins2 -477,
Figure 3A). ChIP analysis showed Nkx2.2 occupancy
with primers for both the published and the newly pre-
dicted site, although occupancy appeared to be stronger
on the PBM-mapping predicted site (Figure 3B).
Although the ChIP results are unable to completely dis-
tinguish between occupancy of both sites because of
their close proximity relative to the DNA fragmentation
size, it is also possible that Nkx2.2 binds the Ins2 -144
site through cooperative binding with cofactors that
would not have been detected by EMSA analysis using
in vitro translated Nkx2.2. Therefore, we performed
additional EMSA analysis using bTC6 nuclear extract
(Figure 6, Additional File 5). A strong shift was observed
when bTC6 nuclear extract was incubated with the Ins2
-477 probe and this shift was inhibited by addition of
Nkx2.2 antibody (Figure 6). A weaker Nkx2.2 containing
complex could also be detected bound to the Ins2 -144
site (Figure 6 and Additional File 5). Therefore, it
appears that Nkx2.2 may be stabilized on the Ins2 -144
site by interacting factors, although this interaction
appears to be much weaker than the -477 site identified
by PBM-mapping.
PBM-mapping accurately predicts Hnf4a binding sites
To test the wider applicability of PBM-mapping for the
general prediction of transcription factor direct targets,
we applied a moving average of E-scores from 6 overlap-
ping octamers to the nuclear receptor family member
Hnf4a. Hnf4a has been shown to bind DNA as a homo-
dimer to a site containing two direct repeats of the con-
sensus binding site (consensus site: AGGTCA) [29].
Therefore, Hnf4a represents a transcription factor that
Figure 6 Nkx2.2 binds the Ins2 promoter through a novel site.
EMSA analysis of putative Nkx2.2 binding sites in the Ins2 promoter.
Probes were incubated with in vitro translated Nkx2.2 or bTC6 nuclear
extract. Supershifts were done using the monoclonal Nkx2.2 antibody.
Figure 5 Nkx2.2 binding to the NeuroD1 promoter through
GAGT and AAGT sites. (A) Schematic representation of the
NeuroD1 promoter. The TRANSFAC PWM predicted two sites that
were not bound in vitro or in vivo [20]. PBM-mapping predicted a
novel site upstream of the other two sites that contains both a
GAGT core and an AAGT core separated by 4 bp. (B) EMSA analysis
showing binding through both core sites. Wildtype, AAGT mutant,
GAGT mutant and double mutant probes were incubated with in
vitro translated Nkx2.2.
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is structurally and functionally distinct from Nkx2.2. We
applied PBM-mapping to 30 putative Hnf4a binding
sites (18 positive and 12 negative) that were previously
tested by EMSA analysis [30]. At a threshold value of
0.26, PBM-mapping predicted 16 of the 18 (89%) con-
firmed binding sites and correctly did not predict any of
the negative sites (Additional File 6). Adding or sub-
tracting the number of overlapping octamers did not
improve prediction scores for the analyzed data set
(data not shown). This data suggests that PBM-mapping
may be directly applicable to a wide range of transcrip-
tion factors.
Discussion
The identification of transcription factor binding sites is an
important biological question. To date, the majority of
methods to detect these sites have focused on creating sta-
tistical models, such as position weight matrices, of tran-
scription factor specificities. However, these models are
limited due to the fact that they must make generalized
assumptions about transcription factor binding properties
that are not completely understood. Other recent technol-
ogies have been developed such as ChIP-Seq to look at
genomic transcription factor occupancy [31]. However,
these technologies do not identify the precise binding
sites, are technically difficult, and limited by the lack of
high quality antibodies for many transcription factors.
Therefore, bioinformatic prediction of transcription factor
binding sites remains a powerful and useful tool for under-
standing transcriptional regulation. In this paper, we pro-
pose a modified technique for creating genome-wide
TFBS site maps using direct mapping of protein binding
microarray data (PBM-mapping). This method is techni-
cally simpler than ChIP-seq methods and does not rely on
the assumptions used in statistical models.
We have shown that PBM-mapping more accurately
predicts relative binding affinity than previously reported
TRANSFAC or PBM based PWMs. PWM inaccuracies
have been attributed to both experimental and theoreti-
cal errors [32]. Our studies support both of these limita-
tions. The TRANSFAC PWM was developed from the
alignment of 23 sequences enriched using SELEX
experiments. The PBM-PWM was based on microarray
experiments, which provide data for all possible octa-
mers. In our experiments, the PBM-PWM was more
highly correlated with observed relative binding affinity
than the TRANSFAC PWM, most likely due to the
increased information content in the PBM-PWM. How-
ever, PBM-mapping scores correlated to a greater extent
with relative binding affinity than either PWM method,
even though it was generated from the same data used
for the PBM-PWM. Therefore, the PWM statistical
model does not accurately model Nkx2.2 binding.
Numerous methods for generating PWMs exist and
there are several statistical corrections that can be
applied to the PWM model, however accurately testing
and comparing all of these corrections is technically dif-
ficult and therefore were outside the scope of this study
[33]. Predictions based on the combined results of more
than one PWM could also be attempted. However, these
predictions would still be susceptible to the limitations
of the PWM model to account for the influence of
neighboring nucleotides and flanking regions.
A method for using the average E-score of 3 overlap-
ping octamers surrounding a previously identified core
sequence (AvgES) has been utilized for predicting bind-
ing sites in C. elegans [22]. However, this method was
not fully tested for accuracy and is biased by the assump-
tion of a completely conserved 4-basepair long core
sequence. Our results show that using an average E-score
from an increased number of overlapping octamers
improved the accuracy of transcription factor binding
site prediction. Interestingly, an average E-score of 7
overlapping octamers resulted in the highest correlation
with relative binding affinity. This represents the greatest
number of overlapping octamers possible with at least
one base pair common between all oligos. Nkx2.2 binding
has been reported to be influenced by the flanking DNA
sequence [16,34]. Therefore, the increase in accuracy is
most likely due to accounting for the flanking regions;
however, it may also be due to reductions in the inherent
noise present from microarray quantification [21]. It
remains possible that bases outside of the 7 octamer win-
dow can affect binding affinity, although using a window
larger than 7 overlapping octamers resulted in decreased
accuracy. This may be due to limitations of using 8 bp
long motifs for generation of PBM data. It remains to be
seen if increasing the length of DNA-binding sequences
used in the microarray based experiments to generate
E-scores would further increase the accuracy of binding
affinity prediction.
We did not observe a large difference between the
flanking regions of “AAGT” and “GAGT” containing
sequences. Furthermore, both core sequences share
common flanking regions in the octamers with the high-
est E-score (TCAAGTGG and TCGAGTGG). However,
the magnitude of the effect that base substitutions in
the flanking regions have of the overall score of the site
differed between “AAGT” and “GAGT” containing sites.
For example, conversion of “G” to “C” in the last posi-
tion of the above mentioned octamers reduces the single
octamer E-score of the “AAGT” site by 0.0038 and the
“GAGT” site by 0.011, confirming that the bases in
these positions are not independently additive, but are
dependent on other bases in the binding site, even when
these bases are not immediately adjacent.
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We tested PBM-mapping using the homeodomain
transcription factor Nkx2.2. Nkx2.2 has been shown to
act as both an activator and a repressor during pancreatic
islet formation [23,35]. b-cells are completely absent in
the Nkx2.2 null embryo [15]. There was also a corre-
sponding decrease in many, but not all, b-cell markers
[25]. However, it was unclear which of these genes were
down-regulated due to direct transcriptional control by
Nkx2.2 or because the b-cell population was absent. We
used PBM-mapping to predict novel Nkx2.2 binding sites
within bound promoters of genes differentially expressed
between wildtype and Nkx2.2 null embryos. Interestingly,
a large majority of differentially expressed genes had pre-
dicted sites, suggesting that between e12.5 and e13.5 the
changes seen in the Nkx2.2 null pancreas are largely due
to direct regulation by Nkx2.2 and not a cascade of
downstream transcription factors. We were also able to
predict binding sites in several b-cell specific genes,
including a battery of genes encoding proteins present in
secretory vesicles, such as insulin, IAPP and ChgB that
appear to be coordinately activated by Nkx2.2.
Several studies have shown that relatively weak or sec-
ondary binding sites are biologically important [1,2].
These sites may create genomic binding profiles depen-
dent on protein concentrations or they may differentially
bind closely related transcription factors that share a
common primary binding motif [3]. Careful analysis of
the PBM data for Nkx2.2 revealed a previously unidenti-
fied alternative “GAGT” binding site motif for Nkx2.2.
GAGT containing sites were also represented in our pre-
dicted sites (Gcg -432, Iapp -1355, Nkx2.2 -716, and
Tm4sf4 -1723)–confirming the ability of the algorithm to
predict secondary sites. This is the first secondary motif
that has been identified for an Nkx2 family member,
although a unique secondary motif has been identified
for Nkx3.1 (GTAC) [3]. PBM-mapping does not predict
that Nkx2.2 binds the GTAC core sequence; however
this is not surprising since the homeodomain sequences
between Nkx2 and Nkx3 family members are not well
conserved and the two protein families are known to pre-
ferentially bind different core sequences [36]. Further
research is necessary to determine whether the GAGT
motif identified in this study is unique to Nkx2.2 or is
shared among several Nkx2 genes.
The importance of weak or secondary binding sites
highlights the importance of finding a suitable threshold
for determining positive prediction results. In our study,
we set the threshold for putative Nkx2.2 binding sites at
0.37 based on the results from our EMSA analysis.
However, this may not accurately reflect in vivo binding.
For example, the Gcg -1080 site, which had an average
E-score just below our threshold, did not show binding
in EMSA analysis (Figure 3A), but appeared to be
occupied in ChIP (Figure 3B). Therefore, it is possible
that our threshold is overly stringent or that Nkx2.2
binding to weak sites is dependent on the presence of
cofactors. The appropriate threshold may also vary
between cell types due to different expression levels of
the transcription factor. Furthermore, our results show
that the appropriate threshold for different transcription
factors will differ.
Conclusions
Although our studies to test PBM-mapping mainly
focused on Nkx2.2, we believe that it could be widely
applied to other transcription factor binding sites.
Homeodomain proteins generally bind to a motif with a
strong 4-5 base pair core with less conserved flanking
sequences [37]; therefore, the PBM-mapping algorithm
should be directly applicable to most homeodomain
containing proteins. We also show that PBM-mapping
can be applied to the nuclear receptor protein Hnf4a,
but with a different threshold score and number of
overlapping octamers than Nkx2.2. Not surprisingly, this
suggests that the different DNA-binding site profiles
associated with each class of protein will necessitate
modifying the number of overlapping octamers used in
each analysis. This will especially apply to transcription
factor classes that contain shorter or longer binding
sites. For example, several zinc finger proteins are
thought to have binding sites that contains a 3-base pair
core, while some bHLH factors have a 6 bp core
sequence [38]. A shorter core sequence may rely more
heavily on flanking sequences for binding specificity,
which would require increased octamer coverage,
whereas a longer core may be more self-contained and
require fewer octamers for predictive coverage. Thresh-
old values may also need to be adjusted for each protein
analyzed. Therefore, adapting this method to other tran-
scription factor families may require a training set of
known binding sites to determine an appropriate thresh-
old for each transcription factor. If previously identified
binding sites are not available, a training set can be gen-
erated from a subset of PBM-mapping predicted sites
that span a wide range of PBM-mapping scores, as was
done in this study. Although small adaptations may be
necessary, the application of this method to other tran-
scription factors merits further investigation.
Methods
Alternative Core Sequence Identification
All octamers with an E-score greater than 0.45 were
selected from the protein binding microarray for Nkx2.2
[4]. Octamers containing “AAGT” or its reverse compli-
ment “ACTT” were removed and the remaining octa-
mers analyzed for common motifs.
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Nkx2.2 and Hnf4a Binding Site Prediction
An algorithm to predict Nkx2.2 binding sites was devel-
oped and implemented in the Perl programming lan-
guage as follows: Chromosome sequence data were
retrieved from the UCSC genome browser website
(http://genome.ucsc.edu). A moving average of the
E-scores from the Nkx2.2 or Hnf4a protein binding
microarrays was calculated for each subset of 7 overlap-
ping octamers across the entire genome. Genomic loca-
tions of putative sites were then saved to a database. For
Nkx2.2, results with an average E-score greater than
0.34 were originally considered positive, but subse-
quently modified to 0.37. For Hnf4a, a threshold value
of 0.24 was used.
Electrophoretic Mobility Shift Assay (EMSA)
In vitro synthesized Nkx2.2 protein was made using the
TNT Coupled Reticulolysate System (Promega).
Nuclear extract was prepared from bTC6 cells using
the Nuclear Extract kit (Active Motif). Probes were
designed for each of the predicted binding sites ana-
lyzed (Additional File 7). Binding reactions were per-
formed as described by [20]. Shifted bands were
quantified using the integrated mean of a fixed window
for each of the shifts using Photoshop Extended CS3
(Adobe). Fraction bound was calculated in order to
estimate the relative binding affinities using densitome-
try analysis of bound DNA compared to total DNA as
measured by EMSA analysis.
Regression Analysis
Regression analysis was performed using Prism 5
(Graphpad). Linear regression was used for PBM-map-
ping score/fraction bound comparisons. Fraction bound
is related to Kd by the equation Kd = [ligand](1-Fraction
Bound)/Fraction Bound. Therefore, the PBM-score
should be correlated with the Kd by the equation Kd = z
(1-(ax + b))/(ax + b). Non-linear regression of PBM-
score predictions of Kd were performed using this equa-
tion as the model to create a best-fit trendline.
Chromatin Immunoprecipitation (ChIP)
ChIP experiments were performed using the ChIP IT
Express kit (Active Motif). bTC6 cells were grown in
DMEM supplemented with 15% FBS. Approximately
1.5 × 107 cells were crosslinked in 1% paraformalde-
hyde for 10 min at room temperature. Chromatin was
then extracted and sheared by sonication using a Diag-
node BioRuptor (8min - 30sec ON/OFF) resulting in
chromatin fragments from 200-800 bp long. The
sheared chromatin was divided into 6 reactions and
run independently. Immunoprecipitations were per-
formed with 3 μg mouse anti-Nkx2.2 monoclonal anti-
body (DSHB). Normal mouse IgG (Millipore) was used
as a negative control. Occupancy of the predicted sites
was tested by Sybr-Green qPCR of two independent
immunoprecipitations (primers are listed in Additional
File 8).
Additional material
Additional file 1: Analysis of Dual Core Sites. Octamers containing
two adjacent 4-bp core sequences were divided into groups based on
content (2 identical cores or a mixture of AAGT and GAGT cores) and
relative orientation (inline or reverse complement). Corresponding E-
scores form PBM analysis are also shown. Octamers with two reverse
complement cores consistently have higher E-scores than inline
octamers regardless of content.
Additional file 2: Enrichment of sites in proximal promoter regions
of genes differentially expressed in the Nkx2.2 null embryo. Putative
Nkx2.2 binding sites were predicted (PBM-mapping score > 0.40) in
promoter regions of 100 randomly chosen genes from genes with no
differential expression between the Nkx2.2 null and wildtype embryos
and compared to the 35 differentially expressed genes. The distance
from the transcriptional start site of the closest predicted site was then
calculated. Differentially expressed genes were more likely to have sites
within 500 bp of the transcriptional start site (P = 0.02). No statistically
significant difference was seen in the other regions.
Additional file 3: Optimization of moving average of E-score values.
A moving average of E-scores containing 1, 3, 5, 6, 7, or 8 overlapping
octomers was calculated and compared to relative binding affinity of
each site. R-squared values are plotted next to each plot. The three sites
that did not bind in our EMSA analysis are plotted along the x-axis to
show their predicted scores compared to bound sites, but were not
used to calculate r-squared values.
Additional file 4: PBM-mapping scores are highly correlated with Kd
values for the Nkx2.2 drosophila homolog vnd. Previously published
Kd values for 22 vnd binding sites were plotted against their respective
PBM-mapping scores. Non-linear regression was performed using a
previously derived equation for the expected relationship between PBM-
mapping scores and Kd values (see Methods).
Additional file 5: An Nkx2.2 containing complex forms on the Ins2
-144 site. Longer exposure (48 hrs) of the EMSA analysis of putative
Nkx2.2 binding sites in the Ins2 promoter shown in Figure 6. Probes
were incubated with in vitro translated Nkx2.2 or bTC6 nuclear extract.
Supershifts were done using the monoclonal Nkx2.2 antibody.
Additional file 6: Confirmation of previously tested Hnf4a sites.
PBM-mapping scores were generated for 18 positive and 12 negative
Hnf4a sites that were previously published (28). At a threshold of 0.26,
16 of the 18 confirmed sites were predicted while all of the negative
sites were not predicted. The two sites that were not predicted, but
were bound in EMSA analysis, are highlighted in Bold.
Additional file 7: List of probes used in EMSA analysis. Forward and
reverse single stranded oligos that were annealed to form double
stranded DNA probes with 5’ overhangs. Probes were then labeled by
Klenow extension to insert a 32P containing dCTP (see Methods).
Additional file 8: List of primers used for qPCR reactions. PCR
primers were designed to amplify an approximately 200 bp region
flanking predicted Nkx2.2 binding sites (see Methods).
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